Clinical trial strategy: Fine-tuning the risk–reward profile
The Swiss Biotech Association and Parexel join forces to address major clinical trial strategy challenges, including the growing complexity of trials, changing regulations, spiraling costs, and patient access. The meeting will explore the impact of real world data science, adaptive clinical trial design, biomarkers and more.
Further information: www.swissbiotech.org/swiss-biotech-insight-20190919/
BIO Deutschland members get a discount for registration fee. Please contact us (email@example.com).